GC-1126A

N/A

Report date: 2024/11/12 15:24:15

Base Information

Drug NameGC-1126A
Drug Alias NameGC1126A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionA disintegrin and metalloproteinase with thrombospondin motifs 13 inhibitors
TargetsA disintegrin and metalloproteinase with thrombospondin motifs 13
Therapy Area/IndicationsPurpura, Thrombotic Thrombocytopenic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGC Biopharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesGC Biopharma Corp
Inactive CompaniesN/A
Active IndicationsPurpura, Thrombotic Thrombocytopenic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A